Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872025 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 6 Pages |
Abstract
Conclusion: Medically inoperable Stage I endometrial carcinoma may be safely and effectively treated with HDRB as the primary therapy. In selected Stage I patients, our results are equivalent to that of surgery. We believe that the alternative option of HDRB as the primary therapy for selected Stage I endometrial carcinoma, even in patients with low operative risks, needs further evaluation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tamim M. M.D., Luis M.D., Lorraine M.D., Boris M.D., Lucy M.D., Gerald M.D.,